(Press-News.org) A spinal cord injury changes the functional state and structure of the spinal cord and the brain. For example, the patients' ability to walk or move their hands can become restricted. How quickly such degenerative changes develop, however, has remained a mystery until now. The assumption was that it took years for patients with a spinal cord injury to also display anatomical changes in the spinal cord and brain above the injury site. For the first time, researchers from the University of Zurich and the Uniklinik Balgrist, along with English colleagues from University College London (UCL), now demonstrate that these changes already occur within 40 days of acute spinal cord injury.
Spinal cord depletes rapidly
The scientists studied 13 patients with acute spinal cord injuries every three months for a year using novel MRI (magnetic resonance imaging) protocols. They discovered that the diameter of the spinal cord had rapidly decreased and was already seven percent smaller after twelve months. A lesser volume decline was also evident in the corticospinal tract, a tract indispensable for motor control, and nerve cells in the sensorimotor cortex. The extent of the degenerative changes coincided with the clinical outcome. "Patients with a greater tissue loss above the injury site recovered less effectively than those with less changes," explains Patrick Freund, the investigator responsible for the study at the Paraplegic Center Balgrist.
Gaining insights into effect of therapies
Treatments targeting the injured spinal cord have entered clinical trials. Gaining insights into mechanisms of repair and recovery within the first year are crucial. Thanks to the use of the new neuroimaging protocols, Freund says, we now have the possibility of displaying the effect of therapeutic treatments on the central nervous system and of rehabilitative measures more quickly. Consequently, the effect of new therapies can also be recorded more rapidly.
"This study is an excellent example of the value of combining the complementary expertise of the two universities," says UCL's Dean of Brain Sciences, Professor Alan Thompson, who is one of the senior authors of the study. "It provides exciting new insights into the complications of spinal cord trauma and gives us the possibility of identifying both imaging biomarkers and therapeutic targets."
INFORMATION:
The findings are the result of a new three-year neuroscience partnership between the Neuroscience Centre Zurich (ZNZ) and UCL.
Literature:
Patrick Freund, Nikolaus Weiskopf, John Ashburner, Katharina Wolf, Reto Sutter, Daniel R Altmann, Karl Friston, Alan Thompson, Armin Curt. MRI investigation of the sensorimotor cortex and corticospinal tract after acute spinal cord injury: a prospective longitudinal study. The Lancet Neurology. July 2, 2013. doi.org/10.1016/S1474-4422(13)70146-7
Contact:
Dr. Patrick Freund
Paraplegic Centre, Uniklinik Balgrist
Tel. +41 44 386 37 37
E-Mail: pfreund@paralab.balgrist.ch
Irreversible tissue loss seen within 40 days of spinal cord injury
2013-07-02
ELSE PRESS RELEASES FROM THIS DATE:
A potentially life-saving protein takes shape
2013-07-02
COLLEGE PARK, MD - A tiny protein called ubiquitin – so named because it is present in every cell of living things as dissimilar as hollyhocks and humans - may hold the key to treatment for a variety of diseases from Parkinson's to diabetes. The protein, found in all eukaryotes (organisms with membranous cells), was considered unimportant when it was described in 1975. But scientists now know ubiquitin takes many different forms and is important in basic cellular processes, from controlling cells' circadian clocks to clearing away the harmful build-up of cells found in ...
UNC researchers discover a gene's key role in building the developing brain's scaffolding
2013-07-02
CHAPEL HILL, N.C. -- Researchers have pinpointed the role of a gene known as Arl13b in guiding the formation and proper placement of neurons in the early stages of brain development. Mutations in the gene could help explain brain malformations often seen in neurodevelopmental disorders.
The research, led by a team at the University of North Carolina School of Medicine, was published June 30 in the journal Nature Neuroscience.
"We wanted to get a better sense of how the cerebral cortex is constructed," said senior study author Eva Anton, PhD, a professor in the Department ...
Gene therapy cures a severe paediatric neurodegenerative disease in animal models
2013-07-02
Sanfilippo Syndrome type A, or Mucopolysaccharidosis type IIIA (MPSIIIA), is a neurodegenerative disease caused by mutations in the gene that encodes the enzyme sulfamidase. Mutations in this gene lead to deficiencies in the production of the enzyme, which is essential for the breakdown of substances known as glycosaminoglicans. If these substances are not broken down, they accumulate in the cells and cause neuroinflammation and organ dysfunction, mainly in the brain, but also in other parts of the body. Children born with this mutation are diagnosed from the age of 4 or ...
GIS scientists discover molecular communication network in human stem cells
2013-07-02
Scientists at A*STAR's Genome Institute of Singapore (GIS) and the Max Planck Institute for Molecular Genetics (MPIMG) in Berlin (Germany) have discovered a molecular network in human embryonic stem cells (hESCs) that integrates cell communication signals to keep the cell in its stem cell state. These findings were reported in the June 2013 issue of Molecular Cell.
Human embryonic stem cells have the remarkable property that they can form all human cell types. Scientists around the world study these cells to be able to use them for medical applications in the future. ...
Fishing in the sea of proteins
2013-07-02
To convert a gene into a protein, a cell first crafts a blueprint out of RNA. One of the main players in this process has been identified by researchers led by Dr. Jessica Jacobs at the Ruhr-Universität Bochum. The team "fished" a large complex of proteins and RNA, which is involved in the so-called splicing, from the chloroplasts of the green alga Chlamydomonas reinhardtii. This cuts non-coding regions out of the messenger RNA, which contains the protein blueprint. "For the first time, we have established the exact composition of an unknown splicing complex of the chloroplasts", ...
Changes in hyaluronan metabolism key in adaptation of keratinocytes to radiation injury
2013-07-02
As the outermost layer of skin, epidermis is crucial in forming a permeability barrier and protection against various environmental agents. Thus, investigating the biology of its most important cell type, the keratinocyte, is key to understanding the effects of solar ultraviolet radiation in skin, and helps design effective means of protection against excessive exposure. It has already previously been shown with both cell culture and in vivo animal models that UV irradiation increases the expression of hyaluronan, which is an important carbohydrate of the extracellular ...
Cadaver study may help clinicians identify patients who can skip ACL reconstruction
2013-07-02
A study by researchers at Hospital for Special Surgery has provided the first evidence that the shape of a person's knee could be a factor in the decision of whether a patient should undergo anterior cruciate ligament (ACL) reconstruction after an ACL tear. The study is published online ahead of print in the Proceedings of the Institution of Mechanical Engineering.
"This is the first study to show that after your ACL is ruptured, the changes in the mechanics of the knee can really be affected by the shape of the knee," said Suzanne Maher, Ph.D., associate director of ...
Fidaxomicin in Clostridium difficile infection: added benefit not proven
2013-07-02
The antibiotic fidaxomicin (trade name: Dificlir) has been approved in Germany since December 2011 for the treatment of adults who have diarrhoea caused by Clostridium difficile. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined the added benefit of fidaxomicin in comparison with current standard therapy. According to this, there is currently no proof of an added benefit. The manufacturer did not submit any studies on non-severe ...
Abiraterone: Hint of considerable added benefit
2013-07-02
Abiraterone acetate (abiraterone for short, trade name: Zytiga) has been approved in Germany since December 2012 for men with metastatic prostate cancer that is not responsive to hormone blockade, who only have mild symptoms or so far none at all, and in whom chemotherapy is not yet indicated. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether abiraterone offers an added benefit compared with the present standard therapy. ...
The ribosome -- a new target for antiprion medicines
2013-07-02
New research results from Uppsala University, Sweden, show that the key to treating neurodegenerative prion diseases such as mad cow disease and Creutzfeldt-Jakob disease may lie in the ribosome, the protein synthesis machinery of the cell. The results were recently published in the Journal of Biological Chemistry.
Prion diseases are fatal neurodegenerative diseases caused by misfolding of prion proteins. Examples of prion diseases are scrapie in sheep, mad cow disease and Creutzfeldt-Jakob disease in human.
What triggers misfolding of the prion proteins to the amyloid ...